Continuous and intermittent itraconazole
β
HAVU; BRANDT; HEIKKILΓ; HOLLMEN; OKSMAN; RANTANEN; SAARI; STUBB; TURJANMAA; PIEP
π
Article
π
1999
π
John Wiley and Sons
π
English
β 783 KB
This multicentre, double-blind, randomized study compared the pharmacokinetics of itraconazole given at 200 mg once daily for 3 months and intermittently at 200 mg twice daily for 1 week per month followed by a 3-week drug-free period for 3 months in the treatment of onychomycosis. Patients were fol